Rl. Sack et al., SLEEP-PROMOTING EFFECTS OF MELATONIN - AT WHAT DOSE, IN WHOM, UNDER WHAT CONDITIONS, AND BY WHAT MECHANISMS, Sleep, 20(10), 1997, pp. 908-915
Differing conclusions regarding the sleep-promoting effects of melaton
in may be the result of the broad range of doses employed (0.1-2000 mg
), the differing categories of subjects tested (normal subjects, insom
niac patients, elderly, etc.), and the varying times of administration
(for daytime vs. nighttime sleep). We conclude that melatonin may ben
efit sleep by correcting circadian phase abnormalities and/or by a mod
est direct soporific effect that is most evident following daytime adm
inistration to younger subjects. We speculate that these effects are m
ediated by interactions with specific receptors concentrated in the su
prachiasmatic nucleus (SCN) that result in resetting of the circadian
pacemaker and/or attenuation of an SCN-dependent circadian alerting pr
ocess.